论文部分内容阅读
目的观察分析益比奥治疗肿瘤化疗相关贫血的临床疗效。方法回顾分析2013年1月~2014年1月在我院采用益比奥治疗肿瘤化疗相关贫血患者38例临床资料，将其随机分为观察组和对照组，每组19例患者，两组患者均采用统一的联合化疗方案，并且化疗强度相同。在此基础上观察组患者给予益比奥治疗。结果治疗6w后观察组患者血红蛋白升高，明显高于对照组，差异具有统计学意义(<0.05)。同时观察组患者治疗有效的有10例，有效率为52.6%，对照组治疗有效的仅有2例，有效率为10.5%，差异具有统计学意义(<0.05)。结论临床中治疗肿瘤化疗相关贫血患者时，在联合化疗的基础上应用益比奥治疗，临床效果明显，不良反应少，用药安全，值得在临床中推广和应用。“,”Objective To observe the PE ratio analysis of the clinical curative ef ect for the treatment of tumor chemotherapy related anemia. Methods Retrospective analysis in January 2013 to January 2014 in our hospital during the period of use is the treatment of tumor chemotherapy related clinical data of 38 cases of patients with anaemia, were randomly divided into observation group and control group, each group of 19 patients, two groups of patients with chemotherapy regimens of national unity, and the intensity of chemotherapy were the same. On the basis of the observation group patients give profit than the treatment. Results Observation group of patients after 6 weeks of hemoglobin, significantly higher than the control group, the dif erence statistical y significant ( <0.05). Ten people in the observation group of patients at the same time ef ective, ef ective rate was 52.6%, ef ective only in 2 cases, control group treatment ef ective rate was 10.5%, the dif erence statistical y significant ( <0.05). Conclusion In clinical treatment of the tumor chemotherapy related anemia patients, on the basis of the combination chemotherapy is the treatment, clinical ef ect, less adverse reactions, drug safety, and worth popularization and application in clinical.